Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:1040

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patten, R. D.
Right arrow Articles by Konstam, M. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Patten, R. D.
Right arrow Articles by Konstam, M. A.

(Circulation. 1998;98:1040.)
© 1998 American Heart Association, Inc.


Book Reviews

Cost Effective Diagnosis and Treatment of Coronary Disease

J. David Talley, MD, Patrick D. Mauldin, PhD, Edmund R. Becker, PhD,eds. J. Willis Hurst, MD, series ed. Topics in ClinicalCardiology. 227 pp. Baltimore, Md: Williams &Wilkins; 1997. $69.00. ISBN 0-683-30302-3.

Richard D. Patten, MD; ; Marvin A. Konstam, MD

New England Medical Center, Tufts University School of Medicine, Boston, Mass

As the modern treatment of cardiovascular disorders becomes more and more expensive, greater emphasis will be placed on cost containment and outcome measures. We are clearly in the midst of a medical economic revolution as managed-care organizations make up an increasing portion of third-party payers. In addition, as the Medicare system confronts future bankruptcy as the baby boomers become senior citizens, cost containment will become an absolute necessity. So follows this timely book on the economics of treatment of cardiovascular disease, edited by a cardiologist (Dr J. David Talley) and 2 epidemiologists (Drs Patrick D. Mauldin and Edmund R. Becker).

The first section of the book summarizes current trends in the cost of managing coronary artery disease. In addition, the authors discuss changes occurring in the third-party-payer environment and update modifications in medical reimbursement. Also included is a brief review outlining the economic principles used in medical cost and outcome analysis, which provides the reader with a basis for the methods and data presented throughout the remainder of the book. The next section reviews strategies for diagnosing coronary artery disease, discussing both invasive and noninvasive strategies and which approach is most appropriate from both a clinical and economic standpoint. Also included is a chapter on appropriate and cost-effective perioperative risk stratification in patients with suspected or known coronary artery disease.

The third and fourth sections review all current data for treatment strategies and their application to acute and chronic coronary syndromes, including both medical therapy and invasive revascularization/treatment strategies. These . . . [Full Text of this Article]